An HIV Vaccine for South-East Asia—Opportunities and Challenges

Recent advances in HIV vaccine development along with a better understanding of the immune correlates of risk have emerged from the RV144 efficacy trial conducted in Thailand. Epidemiological data suggest that CRF01_AE is still predominant in South-East Asia and is spreading in China with a growing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, O’Connell, Robert J., Kim, Jerome H., Excler, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494230/
https://www.ncbi.nlm.nih.gov/pubmed/26344118
http://dx.doi.org/10.3390/vaccines1030348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494230/
https://www.ncbi.nlm.nih.gov/pubmed/26344118
http://dx.doi.org/10.3390/vaccines1030348

Ejemplares similares